Goodwill private company alternative
Defining Issues | March 2021
FASB finalizes private company alternative for timing of goodwill triggering event assessment.

ASU 2021-03 provides an accounting alternative for private companies and not-for-profit entities to assess goodwill impairment triggering events only at reporting dates (interim or annual).
Relevant dates
Private companies and NFPs | |
---|---|
Annual periods – Fiscal years beginning after | December 15, 2019 |
Interim periods – In year of adoption | The earliest interim period in the year of adoption for which financial statements have not been issued (or made available for issuance) |
Early adoption permitted? | Yes, for interim or annual financial statements that have not been issued (or made available for issuance) |
Key impacts:
- Provides an accounting alternative for eligible entities to perform a goodwill trigging event assessment only as of their financial reporting date (interim or annual) instead of throughout the reporting period.
- Does not require an entity to elect the goodwill amortization accounting alternative to qualify for this accounting alternative.
- Allows adoption through an unconditional one-time election after the effective date without the requirement to assess the preferability of the change.
- Requires entities that elect the alternative, but later become ineligible (e.g. after an IPO), to reverse the effects of the accounting alternative. The consequences may include assessing triggering events during interim periods, without using hindsight, to determine if goodwill was impaired.
- Does not affect triggering events for impairment of other assets (e.g. long-lived assets).
Download the document:
Private Companies
Download PDFExplore more

Handbook: Impairment of nonfinancial assets
Latest edition: KPMG in-depth guide to impairment testing, covering the models in ASC 350-20, ASC 350-30 and ASC 360.

Handbook: Business combinations
Latest edition: Our in-depth guide to accounting for acquisitions of businesses, updated for recent application issues.
Meet our team

